Login or sign up
For business

Precision Medicine Network

4.1Β· 11 reviews
Average ratingGreat
4.1/ 5

Based on 11 reviews

536%
436%
327%
20%
10%
Ask AI

Ask AI about Precision Medicine Network

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Sonja Kresojevic
Reviews 1

I have been using their services for a while now and I am extremely satisfied with the results. The company has helped me improve my health and well-being. Their website is user-friendly and the information provided is comprehensive. I would definitely recommend them.

Suha Mishalani
Reviews 1

I recently tried Precision Medicine Network and I must say I am impressed. The website is easy to navigate and the information provided is detailed and informative. The team at Precision Medicine Network is knowledgeable and always ready to help. I highly recommend their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Precision Medicine Network

Precision Medicine Network was co-founded in 2011 by Richard Kellner, CEO, and Dr. Mark Boguski, CMO. PMNI was an outgrowth of the Genomic Medicine Initiative at Harvard Medical School in 2009. The company’s mission is to provide β€œFluency in the language of Precision Medicineℒ” as a basis of connecting providers, patients and payers to overcome barriers and realize the potential of precision healthcare. This is accomplished through β€œCrosswalk Insightβ„’: Oncology,” a platform designed to accelerate the rational adoption of precision medicine. Current users of the system include medical, surgical and radiation oncologists, pathologists and laboratory medicine professionals, pharmaceutical companies, clinical trial developers, diagnostics companies, life science toolmakers, health system executives, medical students, residents and fellows, and oncology nurses and genetic counselors.